Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Clinical trial NCT00865020 · COMPLETED
Trial details
- NCT number
- NCT00865020
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.